XML 22 R7.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash flows from operating activities:    
Net income (loss) $ 24,325 $ (60,131)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation 4,516 4,919
Amortization of intangibles 23,264 23,511
Operating lease expense 4,576 3,933
Asset impairment charges 0 90,330
Amortization of prepaid product discounts 7,440 7,077
Deferred income taxes 5,245 (9,129)
Employee share-based compensation expense 6,742 3,618
Other non-cash items, net 2,418 8,439
Changes in assets and liabilities:    
Trade accounts receivable 23,122 3,575
Inventories and supplies 1,042 (3,165)
Other current assets (19,711) (7,403)
Non-current assets (9,868) (917)
Accounts payable (3,543) (10,145)
Prepaid product discount payments (9,590) (7,321)
Other accrued and non-current liabilities (20,397) (20,723)
Net cash provided by operating activities 39,581 26,468
Cash flows from investing activities:    
Purchases of capital assets (21,670) (14,269)
Purchases of customer funds marketable securities (29) (34)
Proceeds from customer funds marketable securities 29 34
Other (180) 354
Net cash used by investing activities (21,850) (13,915)
Cash flows from financing activities:    
Proceeds from issuing long-term debt 5,000 309,000
Payments on long-term debt (5,000) (52,500)
Net change in customer funds obligations 1,659 (19,407)
Proceeds from issuing shares under employee plans 673 1,736
Employee taxes paid for shares withheld (2,360) (757)
Payments for common shares repurchased 0 (14,000)
Cash dividends paid to shareholders (12,932) (12,714)
Other (1,271) (202)
Net cash (used) provided by financing activities (14,231) 211,156
Effect of exchange rate change on cash, cash equivalents, restricted cash and restricted cash equivalents 1,606 (12,717)
Net change in cash, cash equivalents, restricted cash and restricted cash equivalents 5,106 210,992
Cash, cash equivalents, restricted cash and restricted cash equivalents, beginning of year 229,409 174,811
Cash, cash equivalents, restricted cash and restricted cash equivalents, end of period $ 234,515 $ 385,803